BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 29102279)

  • 1. Microdosimetric Evaluation of Current and Alternative Brachytherapy Sources-A Geant4-DNA Simulation Study.
    Famulari G; Pater P; Enger SA
    Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):270-277. PubMed ID: 29102279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monte Carlo investigation of energy response of various detector materials in ¹²⁵I and ¹⁶⁹Yb brachytherapy dosimetry.
    Selvam TP; Keshavkumar B
    J Appl Clin Med Phys; 2010 Jul; 11(4):3282. PubMed ID: 21081887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microdosimetry-based investigation of biological effectiveness of
    Chattaraj A; Selvam TP
    Phys Med Biol; 2023 Nov; 68(22):. PubMed ID: 37797652
    [No Abstract]   [Full Text] [Related]  

  • 4. The dosimetric feasibility of gold nanoparticle-aided radiation therapy (GNRT) via brachytherapy using low-energy gamma-/x-ray sources.
    Cho SH; Jones BL; Krishnan S
    Phys Med Biol; 2009 Aug; 54(16):4889-905. PubMed ID: 19636084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of a Tungsten-181 HDR brachytherapy source: Analysis of isotope production and source dosimetry.
    Jalbert M; Munro JJ; Medich D
    Appl Radiat Isot; 2024 Aug; 210():111365. PubMed ID: 38796998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of gadolinium concentration and cell oxygen levels on radiobiological characteristics of gadolinium neutron capture therapy technique in brain tumor treatment.
    Shamsabadi R; Baghani HR
    Radiol Phys Technol; 2024 Mar; 17(1):135-142. PubMed ID: 37989987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose and DNA damage modelling of diffusing alpha-emitters radiation therapy using Geant4.
    Ballisat L; De Sio C; Beck L; Guatelli S; Sakata D; Shi Y; Duan J; Velthuis J; Rosenfeld A
    Phys Med; 2024 May; 121():103367. PubMed ID: 38701625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monte Carlo simulation study of an
    Oh G; Lee J; Kim H; Kim W; Kang S; Chung J; Jeong S; Lee H; Yoon M; Lee B
    Front Physiol; 2024; 15():1302301. PubMed ID: 38590693
    [No Abstract]   [Full Text] [Related]  

  • 9. Dosimetric evaluation of radionuclides for VCAM-1-targeted radionuclide therapy of early brain metastases.
    Falzone N; Ackerman NL; Rosales LF; Bernal MA; Liu X; Peeters SG; Soto MS; Corroyer-Dulmont A; Bernaudin M; Grimoin E; Touzani O; Sibson NR; Vallis KA
    Theranostics; 2018; 8(1):292-303. PubMed ID: 29290808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A re-activation model for
    Flynn RT; Smith BR; Adams QE; Patwardhan K; Graves SA; Hopfensperger KM
    Med Phys; 2024 May; 51(5):3604-3618. PubMed ID: 38558460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An inter-comparison between radiobiological characteristics of a commercial low-energy IORT system by Geant4-DNA and MCDS Monte Carlo codes.
    Shamsabadi R; Baghani HR
    Int J Radiat Biol; 2024 Jan; ():1-10. PubMed ID: 38166191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monte Carlo Dosimetric Study of Percutaneous Vertebroplasty and Brachytherapy for the Treatment of Spinal Metastases.
    Rafiepour P; Sina S; Azimi P; Faghihi R
    J Biomed Phys Eng; 2023 Oct; 13(5):443-452. PubMed ID: 37868948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brachytherapy at the nanoscale with protein functionalized and intrinsically radiolabeled [
    Ghosh S; Patra S; Younis MH; Chakraborty A; Guleria A; Gupta SK; Singh K; Rakhshit S; Chakraborty S; Cai W; Chakravarty R
    Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1558-1573. PubMed ID: 38270686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Learning from the past: a century of accuracy, aspirations, and aspersions in brachytherapy.
    Melhus CS; Simiele SJ; Aima M; Richardson S
    Br J Radiol; 2022 Dec; 95(1140):20220500. PubMed ID: 35969474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technical note: Evaluation of a mean value of the number of ionizations in a single event distribution by the variance method in microdosimetry.
    Lindborg L; Rabus H
    Med Phys; 2023 Aug; 50(8):5248-5251. PubMed ID: 37114842
    [No Abstract]   [Full Text] [Related]  

  • 16. Liquid scintillation efficiencies, gamma-ray emission intensities, and half-life for Gd-153.
    Bergeron DE; Cessna JT; Fitzgerald RP; Hamad G; Laureano-Pérez L; Pibida L; Zimmerman BE
    Appl Radiat Isot; 2024 Jan; 203():111108. PubMed ID: 38000166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential of low-dose-rate brachytherapy with iodine-125 in the treatment of local recurrences of prostate cancer after primary high-dose-rate monotherapy.
    Burchardt WM; Chyrek AJ; Bielęda GM; Burchardt E; Chicheł A
    J Contemp Brachytherapy; 2023 Apr; 15(2):103-109. PubMed ID: 37215611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microdosimetric Analysis for Boron Neutron Capture Therapy via Monte Carlo Track Structure Simulation with Modified Lithium Cross-sections.
    Han Y; Geng C; D-Kondo JN; Li M; Ramos-Méndez J; Altieri S; Liu Y; Tang X
    Radiat Phys Chem Oxf Engl 1993; 2023 Aug; 209():. PubMed ID: 37206625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological Characterization of the Effects of Filtration on the Xoft Axxent® Electronic Brachytherapy Source for Cervical Cancer Applications.
    Walter AE; Cosper PF; Nickel KP; Ramesh S; Khan AU; DeWerd LA; Kimple RJ
    Radiat Res; 2023 May; 199(5):429-438. PubMed ID: 37014873
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.